Journal article · 2021
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer
Patient, 15(3), 307–316 · Published 13 October 2021 · DOI 10.1007/s40271-021-00552-w
In brief
“The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer” is a 2021 journal article by Andrea Bever and 4 co-authors, published in Patient. OpenAlex counts 2 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 2
- Most cited in
- 2022 (1)
- Field-weighted impact
- 0.09
- References
- 37
- Authors
- 5
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bever, A., Manthorne, J., Rahim, T., Moumin, L., & Szabo, S. M. (2021). The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer. Patient, 15(3), 307–316. https://doi.org/10.1007/s40271-021-00552-w
MLA 9
Bever, Andrea, et al. “The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer.” Patient, vol. 15, no. 3, 2021, pp. 307–316. https://doi.org/10.1007/s40271-021-00552-w.
Chicago
Bever, Andrea, Jackie Manthorne, Tissa Rahim, Layla Moumin, and Shelagh M. Szabo. 2021. “The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer.” Patient 15 (3): 307–316. https://doi.org/10.1007/s40271-021-00552-w.
Harvard
Bever, A. et al. (2021) ‘The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer’, Patient, 15(3), pp. 307–316. doi:10.1007/s40271-021-00552-w.
IEEE
A. Bever, J. Manthorne, T. Rahim, L. Moumin, and S. M. Szabo, “The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer,” Patient, vol. 15, no. 3, pp. 307–316, 2021, doi: 10.1007/s40271-021-00552-w.
BibTeX
@article{bever2021importance,
title = {{The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer}},
author = {Bever, Andrea and Manthorne, Jackie and Rahim, Tissa and Moumin, Layla and Szabo, Shelagh M.},
journal = {Patient},
year = {2021},
volume = {15},
number = {3},
pages = {307--316},
doi = {10.1007/s40271-021-00552-w},
url = {https://doi.org/10.1007/s40271-021-00552-w}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer survivorship and care
- disease-free survival
- lung cancer survivors
- clinical trial endpoints
- overall survival
- patient perspectives
- treatment goals
- quality of life
- patient agency
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Bever, A., Manthorne, J., Rahim, T., Moumin, L., & Szabo, S. M. (2021). The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer. Patient, 15(3), 307–316. https://doi.org/10.1007/s40271-021-00552-w
How many times has this paper been cited?
2 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Andrea Bever, Jackie Manthorne, Tissa Rahim, Layla Moumin, Shelagh M. Szabo.
What is the DOI of this paper?
10.1007/s40271-021-00552-w, permanently at https://doi.org/10.1007/s40271-021-00552-w. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.